The Enterprise Value as of December 2025 (TTM) for Neuphoria Therapeutics Inc. (NEUP) is -5622531.00

According to Neuphoria Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5622531.00. This represents a change of -99.81% compared to the average of -2985110478.53 of the last 4 quarters.

Neuphoria Therapeutics Inc. (NEUP) Historical Enterprise Value (quarterly & annually)

How has NEUP Enterprise Value performed in the past?

The mean historical Enterprise Value of Neuphoria Therapeutics Inc. over the last ten years is 6.72B. The current -5622531.00 Enterprise Value has changed -108.37% with respect to the historical average. Over the past ten years (40 quarters), NEUP's Enterprise Value was at its highest in in the September 2023 quarter at 6.27B. The Enterprise Value was at its lowest in in the June 2025 quarter at -14082908239.60.

Neuphoria Therapeutics Inc. (NEUP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neuphoria Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neuphoria Therapeutics Inc. (NEUP) Average Enterprise Value

How has NEUP Enterprise Value performed in the past?

The current Enterprise Value of Neuphoria Therapeutics Inc. (NEUP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neuphoria Therapeutics Inc. (NEUP) Enterprise Value vs. Peers

How is NEUP’s Enterprise Value compared to its peers?

Neuphoria Therapeutics Inc.’s Enterprise Value is less than Pheton Holdings Ltd Class A Ordinary Shares (2.32M), less than Inspira Technologies Oxy B.H.N. Ltd. (25.25M), less than Biomerica, Inc. (3.93M), less than Profusa, Inc. Common Stock (25.64M), greater than Aprea Therapeutics, Inc. (-10063033.00), less than Check-Cap Ltd. (9.56M), greater than Innovative Eyewear, Inc. (-6692790335.00), less than BioCardia, Inc. (3.88M), less than Alzamend Neuro, Inc. (1.13M), less than Lifeward Ltd. (12.68M),

Build a custom stock screener for Neuphoria Therapeutics Inc. (NEUP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuphoria Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neuphoria Therapeutics Inc. (NEUP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neuphoria Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.